A typical upstream signal pathway for activation of AP-1 that has been widely studied is the Ras-MAPK-ERK pathway, which is one of several important pathways for targeting therapy in HNSCC [38]. This evidence concerns the gene JUN and head and neck squamous cell carcinoma.